Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.

Lipids in health and disease - 10 Jun 2011

Sentinelli Federica, Romeo Stefano, Maglio Cristina, Incani Michela, Burza Maria A, Scano Francesca, Coccia Federica, Cossu Efisio, Leonetti Frida, Baroni Marco G

Abstract excerpt

BACKGROUND: Apolipoprotein C3 (APOC3) is a component of triglyceride-rich lipoproteins, and APOC3 rs2854116 and rs2854117 polymorphisms have been associated with non-alcoholic fatty liver disease, hypertriglyceridaemia, and insulin-resistance. OBJECTIVE: To determine if the APOC3 variants alter the susceptibility of obese subjects to develop liver damage, hypertrigliceridaemia, and insulin-resistance. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein C-III
Share to Fatty Liver
Share to Insulin Resistance
Share to Italy
Share to Lipid Metabolism
Share to Lipids
Share to Obesity, Morbid
Share to Ultrasonography

Source

Open in PubMed Open full text

Identifiers

PMID: 21663607
DOI: 10.1186/1476-511X-10-93
PMCID: PMC3135552

Genes

APOC3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.PMID 21663607Read ↗

The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.Semantic proximity Read ↗

Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.Semantic proximity Read ↗

Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.Semantic proximity Read ↗

Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.Semantic proximity Read ↗

Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.Semantic proximity Read ↗

Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.Semantic proximity Read ↗

Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.Semantic proximity Read ↗

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.Semantic proximity Read ↗

INSIG2 promoter variant, obesity markers and lipid parameters - No association in a large Slavonic Caucasian population sample.Semantic proximity Read ↗

[Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].Semantic proximity Read ↗

INSIG2 polymorphism is neither associated with BMI nor with phenotypes of lipoprotein metabolism.Semantic proximity Read ↗

Variable effects of the APOC3-482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.